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The distal arthrogryposes (DAs) are a group of disorders characterized by multiple congenital contractures of the
limbs. We previously mapped a locus for DA type 2B (DA2B), the most common of the DAs, to chromosome 11.
We now report that DA2B is caused by mutations in TNNI2 that are predicted to disrupt the carboxy-terminal
domain of an isoform of troponin I (TnI) specific to the troponin-tropomyosin (Tc-Tm) complex of fast-twitch
myofibers. Because the DAs are genetically heterogeneous, we sought additional candidate genes by examining
modifiers of mutant Drosophila isoforms of TnI. One of these modifiers, Tm2, encodes tropomyosin, another
component of the Tc-Tm complex. A human homologue of Tm2, TPM2, enocodes b-tropomyosin and maps to
the critical interval of DA type 1 (DA1). We discovered that DA1 is caused by substitution of a highly conserved
amino acid residue in b-tropomyosin. These findings suggest that DAs, in general, may be caused by mutations in
genes encoding proteins of the contractile apparatus specific to fast-twitch myofibers. This provides a new oppor-
tunity to directly study the etiology and pathogenesis of multiple-congenital-contracture syndromes.
Introduction
A child with an isolated congenital contracture (e.g.,
clubfoot) is born once in every 200–500 live births, and
∼1 of every 3,000 children is born with two or more
body areas affected by congenital contractures (i.e., ar-
throgryposis). Nevertheless, the etiology and pathogen-
esis of congenital contractures in neurologically normal
children remains unclear in the majority of cases, most
of which are sporadic. However, it is clear that the eti-
ology of clubfoot has a genetic component (Andrade et
al. 1998), and autosomal dominant segregation of con-
tractures has been well documented (Hall et al. 1982;
Bamshad et al. 1996a; Krakowiak et al. 1998). In the
mid-1990s, to facilitate the identification of genes caus-
ing contractures, we revised the definition and classifi-
cation of a group of heritable disorders called the “distal
arthrogryposes” (DAs) (Bamshad et al. 1996b). In gen-
eral, the DAs are characterized by nonprogressive, con-
genital contractures of two or more different body areas
without primary neurological and/or muscle disease that
affects limb function. Features common to all DAs in-
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clude a consistent pattern of distal joint involvement,
limited proximal joint involvement, an autosomal dom-
inant inheritance pattern, and widely variable expres-
sivity. Ten different DAs were recognized and classified
hierarchically according to the proportion of features
they share with one another (Bamshad et al. 1996b).
The prototypic DA is DA type 1 (DA1 [MIM
108120]), which is primarily characterized by camp-
todactyly and clubfoot, although the shoulders and hips
may also be affected. The phenotype of DA1 is similar
to that of another DA called “Freeman-Sheldon syn-
drome” (FSS [MIM 193700]). In contrast to DA1, the
phenotype of FSS includes scoliosis, a very small oral
orifice (often only a few millimeters in diameter at
birth), H-shaped dimpling of the chin, deep nasolabial
folds, and blepharophimosis (narrow palpebral fissures)
(Freeman and Sheldon 1938). In some individuals, how-
ever, distinguishing between the diagnosis of DA1 and
FSS can be difficult. Moreover, in some extended fam-
ilies, different individuals have been assigned a diagnosis
of either DA1 or FSS (Klemp and Hall 1995).
In 1997, we described individuals with characteristics
of both DA1 and FSS (Krakowiak et al. 1997). Their
features included a triangular face, downward-slanting
palpebral fissures, prominent nasolabial folds, a small
mouth, small mandible, cervical webbing, severe camp-
todactyly, ulnar deviation, and clubfoot or calcaneo-
valgus deformities (fig. 1). We classified this disorder as
variant FSS, or DA2B (MIM 601680), whereas indi-
682 Am. J. Hum. Genet. 72:681–690, 2003
Figure 1 Typical malformations observed in individuals with
DA2B. A, Hands characterized by camptodactyly and ulnar deviation.
B, Feet showing camptodactyly accompanied by calcaneovalgus de-
formities and a vertical talus or clubfoot (not shown).
viduals meeting the full diagnostic criteria for FSS (Bam-
shad et al. 1996b) were referred to as having classical
FSS, or DA2A. Subsequently, we mapped a locus for
DA2B to chromosome 11p15.5 within a few hundred
kilobases of the telomere (Krakowiak et al. 1997).
We now report that DA2B is caused by mutations in
TNNI2, encoding an isoform of troponin I (TnI) specific
to fast-twitch myofibers. Homologues of TNNI2 have
been studied in a wide variety of model organisms, in-
cluding Drosophila, chick, rabbit, and mouse models
(Mullen and Barton 2000). In Drosophila, TnI mutants
with abnormalities of skeletal muscle architecture caus-
ing wing and limb defects have been available for many
decades (Vigoreaux 2001). These mutants have hyper-
contracted intercostal flight muscles (IFM), a condition
that causes protracted elevation of the wings, reduced
frequency of wing beats, and an awkward, irregular gait
(Beall and Fryberg 1991; Barbas et al. 1993). As a con-
sequence, the TnI locus was named “wings up A” (wup
A) (Hotta and Benzer 1972), although the name was
subsequently changed to “heldup” (Deak 1977; Deak
et al. 1982).
Because of the indispensability of the IFM for flight,
the flightlessness phenotype has been a useful screen-
ing device for identification of genes involved in myo-
genesis. Many of the genes identified encode com-
ponents of the troponin-tropomyosin-actin complex.
This led, in part, to the search for genetic interactions
among alleles of these loci, and a handful of dominant
suppressors of heldup mutants have been identified
(Vigoreaux 2001). Recently, a serine-to-phenylalanine
substitution at amino acid residue 185 of tropomyosin,
encoded by a mutant allele (D53) of tropomyosin-2
(Tm2), was found to be a suppressor of heldup2 (Naimi
et al. 2001). Genetic suppressors are often associated
with their own mutant phenotype, and D53 homozy-
gotes are no exception, exhibiting a significant reduction
in flight ability in comparison with the wild type. The
human homologue of Tm2 (TPM2) maps to chromo-
some 9p11.3 in the critical interval for DA1 (Bamshad
et al. 1994). Moreover, the protein encoded by TPM2
(b-tropomyosin) interacts directly with TnI. Conse-
quently, we consideredTPM2 a candidate gene for other
DAs. Screening of TPM2 led to the identification of a
mutation causing DA1. Thus, mutant alleles encoding
TnI and tropomyosin in Drosophila are both associated
with reduced movement and morphological defects, and
they encode proteins that interact with one another. Mu-




All studies were performed with the approval of the
institutional review board of the University of Utah and
the General Counsel of the Shriners Hospitals for Chil-
dren. After informed consent was obtained, living mem-
bers of each kindred were evaluated by review of their
medical history, completion of a questionnaire, and
physical examination. An individual was considered to
have a diagnosis of DA1 if two or more of the major
clinical manifestations were present (Bamshad et al.
1996b). For DA2B, at least two major features plus two
minor features were required for diagnosis (Krakowiak
et al. 1997). Major diagnostic criteria of the upper limbs
included ulnar deviation, camptodactyly, hypoplastic
and/or absent flexion creases, and overriding fingers at
birth. Major diagnostic criteria of the lower limbs in-
cluded talipes equinovarus, calcaneovalgus deformities,
a vertical talus, and metatarsus varus. Minor diagnostic
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criteria include a triangular face, downward-slanting
palpebral fissures, attached ear lobules, a small mouth,
small mandible, arched palate, cervical webbing, and
short stature.
For DA1, a total of 10 patients with familial disease
and 4 patients with sporadic disease were tested; for
DA2B, 16 patients with familial disease and 18 patients
with sporadic disease were examined. Fourteen patients
with classical FSS (5 familial and 9 sporadic) were also
screened for mutations in TNNI2 and TPM2.
Mutation Analysis of TNNI2 and TPM2
Genomic DNA was prepared from peripheral lym-
phocytes and/or Epstein-Barr virus–transformed lym-
phoblastoid cell lines, using standard techniques. Ge-
nomic DNA sequences were amplified according to the
Qiagen HotStarTaq protocol in 1# buffer (10 mM Tris
[pH 8.3], 40 mM KCl, 1.5 mM MgCl2, and 1# Q so-
lution). The reaction was performed with 25 ng of tem-
plate genomic DNA, 200 mM of dNTPs, 10 pmol of
each primer, and 0.625 U of HotStarTaq DNA poly-
merase in a total reaction volume of 25 ml. Samples were
cycled 30 times in an MJ Research DNA Engine Tetrad,
using a standard three-step PCR profile with an initial
denaturing step at 94C for 15 min and a final extension
step at 72C for 10 min. Annealing temperatures and
primer sequences can be found in tables A and B (online
only). PCR products of TNNI2 were purified on a 2%
agarose gel, and PCR products of TPM2 were purified
using Qiaquick columns (Qiagen). Purified PCR prod-
ucts were sequenced using ABI BigDye Terminator, ver-
sion 2.0, reagent. Sequenced products were loaded on
an ABI 377 automated sequencer and analyzed by Se-
quencing Analysis 3.4.1 and Sequencher 4.1 software
(Genecodes). The forward and reverse strand of exons
1–8 of TNNI2 and exons 1–9 of TPM2, including the
flanking splice-recognition sequences, were analyzed.
The presence of each mutation was confirmed in at
least one affected individual in each kindred by cloning
a PCR-amplified product into pCR2.1 plasmid by use
of the TA cloning kit (Invitrogen), according to manu-
facturer’s recommendations. For each individual, 10
transformed clones and 3 control clones were screened.
Plasmid DNA was isolated with a Qiaprep miniprep kit
(Qiagen) and was subjected to direct sequencing, as de-
scribed above. In all other family members, mutations
were detected by restriction digestion. InTNNI2, a GrA
mutation at position 521 in exon 8 creates a novel MspI
restriction site, and the CrT nonsense mutation at bp
466 of TNNI2 eliminates a BfuAI restriction site. A
CrG missense mutation at position 271 in exon 3 of
TPM2 destroys a novel SacII restriction site. Accord-
ingly, each of these exons—and the regions flanking
it—was amplified from affected and unaffected family
members and was then digested, with the appropriate
restriction enzyme, and gel fractionated. For each mu-
tation, 140 control chromosomes were also screened.
Haplotypes of TNNI2 were constructed by genotyp-
ing each affected individual and his or her parents for
three microsatellite markers: D11S1984, D11S4893,
and D11S1923.
Results
Two different mutations in TNNI2 were found in 4
(∼10%) of 34 kindreds with DA2B (fig. 2). The first
mutation found was a GrA missense mutation at bp
521 that causes an arginine-to-glutamine substitution at
amino acid residue 174 (R174Q). Several factors suggest
that this mutation is probably disease causing. First, the
R174Q mutation results in the substitution of an amino
acid residue that is highly conserved in all isoforms of
TnI and between mice and humans (fig. 3). Second, this
change was found in two unrelated families with DA2B
but was not found in 140 control chromosomes. Third,
in pedigree K2 (fig. 2), the R174Q missense mutation
arises de novo and causes DA2B in all of the children
who inherited it (data not shown).
The second mutation found in TNNI2 was a CrT
nonsense mutation at bp 466 that is predicted to encode
a mutant TnI lacking 26 amino acid residues of the
carboxy-terminus. In kindred K3, this mutation arose
de novo in the affected father and was subsequently
transmitted to all of his offspring, each of whom is
affected and has a different mother (fig. 2). The segre-
gation of this mutation in kindred K4 suggests either
that it arose de novo twice or that mosaicism for this
mutation exists in one of the phenotypically normal
parents. However, the level of mosaicism may be too
low to be detected in lymphocytes and/or may exist in
cell populations that were not tested (e.g., gonadal tis-
sue). In each of the kindreds in which we found a dis-
ease-causing mutation in TNNI2, the mutation arose
on a different haplotype background (data not shown).
In addition, these mutations were found on both ma-
ternally and paternally derived chromosomes from dif-
ferent kindreds.
Patients with sporadic DA2B and those belonging
to families with only an affected parent-child pair,
which are uninformative for linkage studies, were also
screened for mutations in TNNI2 by sequencing all of
the exons and one of the known regulatory regions of
TNNI2 (Mullen and Barton 2000). No disease-causing
mutations were found. To look for large deletions that
may not be detected via sequencing of genomic regions,
we screened for allelic dropout, using a battery of mi-
crosatellites that bracket TNNI2. In addition, we used
long-range PCR to amplify genomic regions of ∼2–3 kb
spanning entire exons and introns, and we looked for
Figure 2 Electropherograms of mutations in exon 8 of TNNI2. A, GrA missense mutation at position 521 in exon 8 of TNNI2 in
kindreds K1 and K2. The mutation creates a novel MspI restriction site. Digests of TNNI2 amplicons from an affected individual (lane B)
fractionate into four fragments (243 bp, 166 bp, 110 bp, and 56 bp), whereas only three fragments (243 bp, 110 bp, and 56 bp) are observed
in an unaffected individual (lane D). Lanes A and C, Undigested control samples. B, CrT nonsense mutation at bp 466 of exon 8 of TNNI2
in kindreds K3 and K4. The mutation eliminates a BfuAI restriction site. Digests of TNNI2 amplicons from two affected sibs in kindred K4
(lanes C and D) fractionate into two fragments (409 bp and 344 bp), whereas only one fragment (344 bp) is found in the unaffected parents
(lanes A and B). The 65-bp product cannot be observed on this gel.
Sung et al.: Mutations Causing Distal Arthrogryposis 685
Figure 3 Alignment of genes encoding isoforms of TnI specific to fast-twitch muscle fibers (TNNI2) in humans and mice, slow-twitch
muscle fibers (TNNI1), and cardiac muscle (TNNI3). The positions of the R156Ter and R174Q mutations are indicated.
amplicons of aberrant size; none were found. In these
patients, DA2B may be caused by mutations in regu-
latory regions of TNNI2 that were not screened, or
DA2B may be genetically heterogeneous.
TPM2 was screened for mutations in 14 probands
with DA1. Only a single mutation in TPM2 was found.
This was a CrG missense mutation at bp 271 that re-
sults in an arginine-to-glycine substitution at amino acid
residue 91 (R91G) (fig. 4). It was found in the proband
and affected family members of the kindred originally
used to map DA1 to chromosome 9. This mutation is
predicted to cause a nonconservative amino acid sub-
stitution of a residue that is invariant among mouse,
chick, and jellyfish homologues of TPM2 (fig. 5). Of
the remaining 13 probands with DA1 who either had
sporadic disease or belonged to families with only an
affected parent and child, screening TNNI2 by sequenc-
ing of all of its exons did not reveal any additional
disease-causing mutations.
Fourteen individuals with classical FSS were screened
for mutations in TNNI2 and TPM2. No disease-causing
mutations were found.
Discussion
DA2B and DA1 are caused by mutations in TNNI2 and
TPM2, respectively. Mutations were found in a total of
5 patients with DA from a collection of 48 probands
that were screened, and all of these patients had familial
disease. This includes a kindred in which two affected
children have normal parents. This finding may explain
why DA appears to sometimes segregate in an autosomal
recessive pattern, an inference based on anecdotal re-
ports of multiple affected sibs born to unaffected parents
(Hall 1985). No mutations were found in any patients
with sporadic DA, suggesting that the etiology of con-
genital contractures in patients with sporadic disease
may be different from that in patients with familial
disease.
We suggested elsewhere that DA1 is a genetically het-
erogeneous condition (Bamshad et al. 1994). However,
this was based on the observation that linkage to chro-
mosome 9 was excluded in a second family with DA1
that was later reclassified as having DA2B (family T
[Bamshad et al. 1994]), and linkage data from other
available families with DA1 do not exclude the locus
on chromosome 9 (M.B., J.C.C., and L.B.J., unpublished
data). Thus, it is not clear whether DA1 is genetically
heterogeneous or there are mutations in regions of
TPM2 that have not been screened. It has been hy-
pothesized elsewhere that DA2B and classical FSS may
be caused by mutations in the same gene (Klemp and
Hall 1995; Krakowiak et al. 1997). The hypothesis was
based, in part, on the observation that some individuals
with DA2B, including some in the kindred used to map
DA2B to chromosome 11p15.5 (K1 in fig. 2), had phe-
notypes similar to those of individuals with classical
FSS. No mutations were found in TNNI2 in any of the
probands with classical FSS; thus, its etiology remains
unknown.
Missense mutations in TPM2 have been reported in
two probands with nemaline rod myopathy (Donner et
al. 2002). One individual had a Q147P substitution and
presented with difficulty walking and weakness at 12
years of age. Another had an E117K substitution and
presented with severe hypotonia, mild facial weakness,
and ankle contractures at 4 years of age. None of the
individuals with DA1 caused by a mutation in TPM2
had abnormal results on neurological examination, nor
were nemaline rods found on histological analysis of
the skeletal muscle of several individuals. Thus, al-
though some clinical findings are common to both dis-
orders, the phenotypes are easy to distinguish from one
another. Interestingly, nemaline rod myopathy can also
be caused by mutations in TPM3, which encodes g-
tropomyosin and TNNI1, a homologue of TNNI2,
both of which are expressed predominately in slow-
twitch myofibers (Johnston et al. 2000). The different
phenotypes caused by mutations in genes encoding tro-
pomyosins and troponins may provide further insights
about the functional properties of these proteins.
The mechanism by which mutations in TPM2 and
TNNI2 cause multiple congenital contractures is un-
clear. In all vertebrates, the contraction of skeletal mus-
cle is dependent on an increase in the intracellular con-
centration of Ca2 ions that produces a conformational
change in the contractile machinery of the muscle and
thus muscle contraction (Clark et al. 2002). The sensor/
regulator of Ca2 ion levels in skeletal muscle is the
troponin complex, which is composed of three subunits,
troponin T (TnT), troponin C (TnC), and TnI. TnI binds
actin-tropomyosin and prevents muscle contraction by
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Figure 4 Top, Pedigree of family K5. Bottom, electropherogram of a mutation on exon 3 and digests of amplicons. A, Electropherogram
of a CrG missense mutation at position 271 in exon 3 of TPM2. The mutation creates a novel SacII restriction site in kindred K5. B, Digests
of TPM2 amplicons from an affected individual. The digests from this individual separate into three fragments (320 bp, 218 bp, and 102 bp)
(lane B), whereas amplicons from an unaffected individual remain undigested (lane D). Lanes A and C, Undigested control amplicons.
inhibiting actomyosin ATPase activity. TnC binds Ca2
ions, leading to a conformational change that relieves
TnI inhibition on actomyosin ATPase activity. Yet, its
sensitivity to Ca2 ions appears to be determined, in
part, by the carboxy-terminal residues of TnI (Digel et
al. 2001; Burton et al. 2002).
Mutations in the TNNI2 paralogue, TNNI3, encod-
ing a cardiac-specific isoform of TnI, can cause a car-
diomyopathy by either a dominant-negative effect or
haploinsufficiency (Seidman and Seidman 2001). In
TNNI3, substitution of amino acid residues homolo-
gous to those juxtaposed on either side of R174Q in
TNNI2 result in diminished sensitivity to Ca2 ions and
a reduction in contractile force leading to the devel-
opment of a cardiomyopathy (Watkins et al. 1995; Mur-
phy et al. 2001). For example, a glycine-to-serine sub-
stitution of amino acid residue 203 results in decreased
maximal contractile force and diminished sensitivity to
Ca2 ions (Burton et al. 2002). Similarly, deletion of the
17 carboxy-terminal amino acid residues of TnI,
thought to occur in the heart during myocardial stun-
ning, results in diminished sensitivity to Ca2 ions and
reduced contractility (McDonough et al. 1999). Trans-
genic mice expressing a gene encoding this truncated
protein also develop diminished responsiveness to Ca2
ions, diminished contractility, and ventricular dilata-
tion—recapitulating the stunned myocardium (Murphy
et al. 2000). The R156Ter mutation predicted to delete
the 26 carboxy-terminal amino acid residues of TnI spe-
cific to fast-twitch myofibers might have a comparable
effect. Accordingly, we hypothesize that both substitu-
tion and deletion mutants of the carboxy-terminus of
fast-twitch–specific TnI result in diminished respon-
siveness to Ca2 ions, leading to reduced muscle con-
traction and congenital contractures.
It is also possible that the contractures observed in
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Figure 5 Alignment of isoforms of b-tropomyosin from six animal species. The R91G substitution replaces an arginine residue that is
invariant among species.
individuals with DA2B are caused by perturbation of a
nontraditional function of TnI. The TnI isoform en-
coded by TNNI2 has recently been discovered to bind
to bFGF, to inhibit capillary endothelial cell prolifera-
tion (Feldman and Rouleau 2002), and to be a potent
inhibitor of angiogenesis in human cartilage (Moses et
al. 1999). Other proteins of the contractile apparatus
(e.g., actin) are also found in cellular compartments that
are different from their conventional location, although
their function in these compartments is unknown.
b-Tropomyosin is a coiled-coil protein that binds
head to tail along the length of the actin filament. It is
negatively charged overall, and the R91G substitution
is predicted to cause a local reduction in surface charge
that may alter both the local conformation of the coiled
coil and its flexural rigidity (fig. 6). This could influence
its interactions with actin, which are thought to be crit-
ical for thin-filament regulation (Squire and Morris
1998). Glycine residues in porcine cardiac and rabbit
skeletal a-tropomyosins appear to be compatible with
the overall helical character of the protein suggested by
low-resolution crystal structures (Whitby and Phillips
2000). A glycine side chain might, however, create an
irregularity in the coiled coil, resulting in a region of
increased flexibility that affects thin-filament regulation.
Interestingly, a missense mutation in TPM3 that causes
nemaline rod myopathy encodes a g-tropomyosin mol-
ecule that folds abnormally and exhibits reduced sen-
sitivity of actomyosin ATPase activity in the presence
of Ca2 ions (Moraczewska et al. 2000). Thus, the re-
duced sensitivity of actomyosin ATPase to Ca2 ions
may be the mechanism that causes congenital contrac-
tures in individuals with DA1.
The hypothesis that some DA disorders have a myo-
pathic origin has been tendered for two decades (Hall
et al. 1982), yet many affected individuals have never
undergone a muscle biopsy, and the findings, if any, in
those who do undergo biopsy are typically nonspecific.
Moreover, the site of the muscle biopsy is commonly
chosen for its convenience (e.g., quadriceps) and is usu-
ally not a muscle rich in fast-twitch myofibers. Of the
existing anecdotal reports of the muscle histology of
children affected with various DAs, a single case report
is noteworthy. It describes a paucity of fast-twitch myo-
fibers in an individual with a phenotype resembling
DA2B (Vanek et al. 1986). Our results suggest that fur-
ther study of muscles rich in fast-twitch myofibers in
children with DA1 and DA2B is warranted.
Although the expression of TnI isoforms is restricted
among adult muscle fiber types, the spatial expression
patterns of these genes during development is not (Zhu
et al. 1995). In the developing skeletal muscle of mice,
isoforms of TnI are first expressed in the myotome of
somites at 9.5 days post conception (dpc). The slow-
twitch isoform is expressed first in all newly formed
myotubes, regardless of the future fiber type. As primary
myotubes develop into secondary myotubes (14–16
dpc), expression of the fast-twitch isoform of TnI in-
creases. The timing of this switch between isoforms is
intriguing, because, in our experience with half a dozen
patients for whom a diagnosis of DA2B was established
prenatally, the limbs are often normal during the first
18–20 wk of gestation. It is typically over the next 6–8
wk that the contractures of the hands and feet become
recognizable via ultrasonography. Although there are
no data on the temporal and spatial expression patterns
of TnI isoforms in humans, the onset of expression of
a mutant TNNI2 during myogenesis appears to coincide
with our ability to detect fetal contractures in DA2B.
In newborn mice, the expression of slow-twitch TnI
is stronger in “deep” muscles containing predominately
slow-twitch fibers (e.g., soleus), whereas expression of
fast-twitch TnI is stronger in more-peripheral muscles
(e.g., tibialis anterior and extensor digitorum longus)
(Zhu et al. 1995). The homologous peripheral muscles
in humans also contain predominately fast-twitch my-
ofibers and control the movements of body areas af-
fected in individuals with DA2B. In contrast, expression
of TPM2 is lower in fast-twitch myofibers than in slow-
twitch myofibers. However, the expression of b-tropo-
myosin protein is higher in fast-twitch myofibers (Pieple
and Wieczorek 2000). Thus, the spatial expression pat-
tern of TPM2 also reflects the peripheral distribution
of contractures in individuals with DA1.
In 1991, Beall and Fyrberg discovered that the orig-
inal heldup allele (i.e., heldup2), a troponin mutant, was
caused by an alanine-to-valine substitution. A variety
of heldup alleles with phenotypes varying in severity
Figure 6 A, Homology model of human b-tropomyosin dimer with a molecular surface colored by relative surface electrostatic charge.
The model is based on the 7-A˚ crystal structure of porcine cardiac a-tropomyosin dimer (Protein Database entry 1C1G). A partially transparent
molecular surface is shown colored by electrostatic charge: red indicates regions dominated by negative charge; white indicates areas that are
neutral; blue indicates positive charge. Relatively few positively charged arginine and lysine surface amino acid side chains are found outside
the N-terminal region. The sparse positively charged amino acids are largely neutralized by the large number of surface negatively charged
aspartate and glutamate amino acids, which creates the dominant negatively charged surface character of the molecule. A ribbon model (gray)
shows the characteristic coiled-coil fold of tropomyosin and is visible through the partially transparent molecular surface. “N” indicates the
relatively positively charged N-terminal region, which is important for end-to-end polymerization, and “284” indicates the C-terminus. Box
indicates the region of the molecule surrounding residue 91 shown in detail (panels B and C). B, Detailed view of the area of surrounding
residue 91. A ball-and-stick model of the Arg91 side chain is colored by atom type and is visible through the partially transparent molecular
surface. The positive charge provided by Arg90 and Arg91 is flanked by negative charge, characteristic of the molecule as a whole. C, Detailed
view of the area surrounding residue 91 with R91G mutation. Mutation to glycine neutralizes the positive charge at that position, leading to
an increase in local negatively charged character, seen as an increase in red color in panel C relative to panel B. Figures were generated with
the program Swiss PDB Viewer.
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from embryonic lethal to mild abnormalities of flight
performance and jump ability have subsequently been
described. No substantial differences were noted be-
tween the phenotypes of the individuals with different
alleles of TNNI2, although each of these mutant alleles
disrupts the same domain of TnI. The IFM of many
heldup mutants show nearly normal morphogenesis
but subsequently begin to hypercontract, leaving only
stumps near their attachment points in newly emerged
flies. This recapitulates the reports of misplaced, hy-
poplastic, or absent tendons in some individuals with
DA (Hall et al. 1982), as well as in those in whom we
identified mutations in TNNI2.
The spatial and temporal expression patterns of genes
encoding proteins of the Tc-tropomyosin-actin complex
in fast-twitch fibers may not be regulated independently
in patients with DA. For example, a lack of TnT in
Drosophila results in a secondary reduction of tropo-
myosin and actin (Fyrberg et al. 1990). This indicates
that a feedback mechanism tightly coordinates the ex-
pression of interrelated genes and proteins. Accordingly,
abnormalities of other proteins of the Tc-tropomyosin-
actin complex in fast-twitch myofibers may cause other
multiple-congenital-contracture disorders. We suspect
that the development of DA may be a final common
outcome of mutations that alter the function and stoi-
chiometry of any one of the proteins of the Tc-tropo-
myosin-actin complex in fast-twitch fibers. This would
be analogous to the observation that mutations in
genes encoding many of the isoforms of the Tc-tropo-
myosin-actin complex in cardiac muscle can cause a
cardiomyopathy.
Acknowledgments
We would like to thank the families for their participation,
generosity, and patience. We are indebted to the Freeman-Shel-
don Parents Support Group for their enthusiasm and perse-
verance. We would like to thank J. Hall, K. Flanigan, and two
anonymous reviewers, for discussion, review, and comments.
This project was completed with the support of the Shriners
Hospitals for Children and National Institutes of Health grant
PHS M01-00064 to the General Clinical Research Center at
the University of Utah.
Electronic-Database Information
Accession numbers and the URL for data presented herein
are as follows:
Online Mendelian Inheritance in Man (OMIM) http://www
.ncbi.nlm.nih.gov/Omim/ (for DA1 [MIM 108120], DA2B
[MIM 601680], and FSS [MIM 193700])
References
Andrade MD, Barnholtz JS, Amos CI, Lockmiller C, Scott A,
Risman M, Hecht J (1998) Segregation analysis of idiopathic
talipes equinovarus in a Texan population. Am J Med Genet
79:97–102
Bamshad M, Bohnsack JF, Jorde LB, Carey JC (1996a) Distal
arthrogryposis type 1: clinical analysis of a large kindred.
Am J Med Genet 65:282–285
Bamshad M, Jorde LB, Carey JC (1996b) A revised and ex-
tended classification of the distal arthrogryposes. Am J Med
Genet 65:277–281
Bamshad M, Watkins WS, Zenger RK, Bohnsack JF, Carey JC,
Otterud B, Krakowiak PA, Robertson M, Jorde LB (1994)
A gene for distal arthrogryposis type 1 maps to the peri-
centromeric region of chromosome 9. Am J Hum Genet 55:
1153–1158
Beall CJ, Fyrberg E (1991) Muscle abnormalities inDrosophila
melanogaster heldup mutants are caused by missing or ab-
errant troponin-I isoforms. J Cell Biol 114:941–951
Barbas JA, Galceran J, Torroja L, Prado A, Ferrus A (1993)
Abnormal muscle development in the heldup mutant ofDro-
sophila melanogaster is caused by a splicing defect affecting
selected troponin I isoforms. Mol Cell Biol 13:1433–1439
Burton D, Abdulrazzak H, Knott A, Elliott K, Redwood C,
Watkins H, Marston S, Ashley C (2002) Two mutations in
troponin I that cause hypertrophic cardiomyopathy have
contrasting effects on cardiac muscle contractility. Biochem
J 362:443–451
Clark KA, McElhinny AS, Beckerle MC, Gregorio CC (2002)
Striated muscle cytoarchitecture: an intricate web of form
and function. Annu Rev Cell Dev Biol 18:637–706
Deak II (1977) Mutations in Drosophila melanogaster that
affect muscles. J Embryol Exp Morphol 40:885–895
Deak II, Bellamy PR, Bienz M, Dubuis Y, Fenner E, Gollin M,
Rahmi A, Ramp T, Reinhardt CA, Cotton B (1982) Mu-
tations affecting the indirect flight muscles of Drosophila
melanogaster. J Embryol Exp Morphol 69:61–81
Digel J, Abugo O, Kobayashi T, Gryczynski Z, Lakowicz JR,
Collins JH (2001) Calcium- and magnesium-dependent in-
teractions between the C-terminus of troponin I and the N-
terminal, regulatory domain of troponin C. Arch Biochem
Biophys 387:243–249
Donner K, Ollikainen M, Ridanpa¨a¨ M, Christen H-J, Goebel
HH, de Visser M, Pelin K, Wallgren-Pettersson C (2002)
Mutations in the b-tropomysin (tPM2) gene: a rare cause of
nemaline myopathy. Neuromuscul Disord 12:151–158
Feldman L, Rouleau C (2002) Troponin I inhibits capillary
endothelial cell proliferation by interaction with the cell’s
bFGF receptor. Microvasc Res 63:41–49
Freeman E, Sheldon J (1938) Cranio-carpotarsal dystrophy:
undescribed congenital malformation. Arch Dis Child 13:
277–283
Fyrberg, E, Fyrberg CC, Beall C, Saville DL (1990) Drosophila
melanogaster troponin-T mutations engender three distinct
syndromes of myofibrillar abnormalities. J Mol Biol 216:
657–675
Hall JG (1985) Genetic aspects of arthrogryposis. Clin Orthop
194:44–53
Hall JG, Reed SD, Green G (1982) The distal arthrogryposes:
690 Am. J. Hum. Genet. 72:681–690, 2003
delineation of new entities—review and nosologic discus-
sion. Am J Med Genet 11:185–239
Hotta Y, Benzer S (1972) Mapping of behaviour in Drosophila
mosaics. Nature 240:527–535
Johnston JJ, Kelley RI, Crawford TO, Morton DH, Agarwala
R, Koch T, Scha¨ffer AA, Francomano CA, Biesecker LG
(2000) A novel nemaline myopathy in the Amish caused by
a mutation in troponin TI. Am J Hum Genet 67:814–821
Klemp EL, Hall JG (1995) Dominant distal arthrogryposis in
a Maori family with marked variability of expression. Am
J Med Genet 55:414–419
Krakowiak PA, Bohnsack JF, Carey JC, Bamshad M (1998)
Clinical analysis of a variant of Freeman-Sheldon syndrome
(DA2B). Am J Med Genet 76:93–98
Krakowiak PA, O’Quinn JR, Bohnsack JF, Watkins WS, Carey
JC, Jorde LB, Bamshad M (1997) A variant of Freeman-
Sheldon syndrome maps to 11p15.5-pter. Am J Hum Genet
60:426–432
McDonough JL, Arrell DK, Van Eyk JE (1999) Troponin I
degradation and covalent complex formation accompanies
myocardial ischemia/reperfusion injury. Circ Res 84:9–20
Moraczewska J, Greenfield NJ, Liu Y, Hitchock-DeGregori SE
(2000) Alteration of tropomyosin function and folding by
a nemaline myopathy-causing mutation. Biophys J 79:3217–
3225
Moses MA, Wiederschain D, Wu I, Fernandez CA, Ghazizadeh
V, Lane WS, Flynn E, Sytkowski A, Tao T, Langer R (1999)
Troponin I is present in human cartilage and inhibits an-
giogenesis. Proc Natl Acad Sci USA 96:2645–2650
Mullen AJ, Barton PJR (2000) Structural characterization of
the human fast skeletal muscle troponin I gene (TNNI2).
Gene 242:313–320
Murphy AM, Ko¨gler H, Georgakopoulos G, McDonough JL,
Kass DA, Van Eyk JE, Marba´n E (2000) Transgenic mouse
model of stunned myocardium. Science 287:488–491
Naimi B, Harrison A, Cummins M, Nongthomba U, Clark S,
Canal I, Ferrus A, Sparrow JC (2001) A tropomyosin-2 mu-
tation suppresses a troponin I myopathy in Drosophila. Mol
Biol Cell 12:1529–1539
Pieples K, Wieczorek DF (2000) Tropomyosin 3 increases stri-
ated muscle isoform diversity. Biochemistry 39:8291–8297
Seidman JG, Seidman C (2001) The genetic basis for cardio-
myopathy: from mutation identification to mechanistic par-
adigms. Cell 104:557–567
Squire JM, Morris EP (1998) A new look at thin filament
regulation in vertebrate skeletal muscle. FASEB J 12:761–
771
Vanek J, Janda J, Amblerova´ V, Flosan F (1986) Freeman-
Sheldon syndrome: a disorder of congenital myopathic or-
igin. J Med Genet 23:231–236
Vigoreaux JO (2001) Genetics of the Drosophila flight muscle
myofibril: a window into the biology of complex systems.
Bioessays 23:1047–1063
Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R,
O’Donoghue A, Spirito P, Matsumori A, Moravec CS, Seid-
man JG, Seidman CE (1995) Mutations in the genes for
cardiac troponin T and a-tropomyosin in hypertrophic car-
diomyopathy. N Engl J Med 332:1058–1064
Whithy FG, Phillips GN Jr (2000) Crystal structure of tro-
pomyosin at 7 angstroms resolution. Proteins 38:49–59
Zhu L, Lyons GE, Juhasz O, Joya JE, Hardeman EC, Wade
R (1995) Developmental regulation of troponin I isoform
genes in striated muscles of transgenic mice. Dev Biol 169:
487–503
